Overview of Ascodex Plus

Quick Facts

Property	Description
Active Ingredients	Ammonium Chloride, Bromhexine, Diphenhydramine, Guaifenesin, Menthol
Form	Oral Solution (Syrup)
Pharmacological Class	Compound Cough Preparation, Multi-component Respiratory Agent
General Purpose	Facilitation of phlegm clearance and relief of cough-related irritation
Origin	Fixed-Dose Combination of Synthetic and Derived Components

What Type of Medicine is Ascodex Plus?

Ascodex Plus is a fixed-dose combination (FDC) cough preparation classified as a multi-component respiratory tract agent, formulated as an oral solution (syrup). This medication's identity is defined by its strategic integration of active ingredients from several distinct pharmacological classes into a single formulation. Unlike single-ingredient syrups, this compound preparation aims to deliver a coordinated therapeutic approach, addressing multiple aspects of a productive cough within one medicine. The active components are primarily synthetic compounds combined in an aqueous syrup base for oral administration, ensuring the systemic delivery of the active agents. This specific five-component FDC is often marketed for its broad action in managing symptoms associated with the common cold and bronchitis.

Ascodex Plus: Understanding the Five Active Ingredients

The formulation is characterized by the presence of five specific active ingredients: Bromhexine, Guaifenesin, Ammonium Chloride, Diphenhydramine, and Menthol. This composition deliberately blends a mucolytic agent (Bromhexine), multiple expectorants (Guaifenesin and Ammonium Chloride), an H1-receptor antagonist (Diphenhydramine), and a localized soothing agent (Menthol). Guaifenesin is an established expectorant commonly used to help loosen phlegm, confirming its role in thinning secretions. The selection of these compounds is based on established principles of cough management, and the combined use of mucolytics and expectorants is clinically recognized for improving secretion clearance.

What is the General Purpose of This Combination Syrup?

The general purpose of the Ascodex Plus combination syrup is to facilitate the efficient clearance of thick, accumulated phlegm and provide concurrent relief from associated airway irritation. By reducing the thickness and stickiness of bronchial secretions, the medicine helps the body convert a difficult, congested cough into a more effective, productive cough. The inclusion of Diphenhydramine, a first-generation antihistamine, contributes to the overall purpose by diminishing the intensity and frequency of the cough reflex, a known effect of this class of agent. This multi-target approach makes the formulation useful for general respiratory discomfort characterized by a wet cough and associated congestion.

What side effects are possible with Ascodex Plus?

Possible Side Effects and Safety Information

The safety profile of Ascodex Plus is formally defined by regulatory authorities, classifying documented adverse reactions by frequency and the body system affected.

Documented Adverse Reactions

Side effects commonly reported in regulatory documents (often categorized as Common or Very Common) are generally temporary and may include:

System Organ Class	Common Adverse Reactions
Nervous System	Headache, Drowsiness/Sleepiness, Dizziness, Impaired coordination, Tremor
Gastrointestinal	Nausea, Vomiting, Diarrhea, Indigestion, Stomach pain
Skin	Rash, Hives (Urticaria)
Cardiac	Palpitations, Increased heart rate (Tachycardia)

Serious Adverse Reactions and Key Restrictions

Serious Adverse Reactions officially noted include the risk of Severe Allergic Reactions (Hypersensitivity). Signs such as difficulty breathing or swelling of the face, tongue, or throat require immediate medical attention.

Safety-Related Limitations: Use is subject to mandatory constraints as defined in the label:

Activity Restriction: Individuals must avoid driving or operating machinery due to the risk of drowsiness and dizziness.
Alcohol: Concomitant use with alcohol is restricted as it may significantly increase sedation.
Contraindications: The medicine is formally contraindicated in individuals with known allergy/hypersensitivity to any component.

Population-Specific Safety

Official cautions are placed on specific patient groups:

Pregnancy and Breastfeeding: Use is generally not recommended due to limited safety data.
Hepatic/Renal Impairment: Caution is required, and the dose may need adjustment in individuals with existing liver or kidney disease.
Pre-existing Conditions: Caution is necessary in patients with existing cardiac disorders (e.g., hypertension), glaucoma, hyperthyroidism, or a history of seizures.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose involving this multi-component product is a serious scenario defined by specific clinical manifestations documented in official regulatory information. Due to the active ingredients, the overdose profile includes documented risks to the Central Nervous System (CNS) and the Cardiovascular System.

Documented Manifestations and Severe Outcomes

An overdose may present initially with CNS depression, including somnolence and sedation. Anticholinergic signs, such as tachycardia (fast heart rate), dry mouth, and mydriasis (dilated pupils), are officially documented manifestations. Gastrointestinal upset, including nausea and vomiting, is also listed. Regulatory documents classify specific outcomes as severe or life-threatening. These include major neurological events such as seizures and progression to coma. Significant cardiovascular risks, including cardiac arrhythmias and QRS interval prolongation, are officially noted, and the risk of metabolic acidosis is documented following excessive ingestion. A specific consideration noted in official labeling is the potential for paradoxical CNS excitation and agitation in pediatric patients.

Required Emergency Action

In any case of suspected overdose, it is essential to seek immediate medical attention and contact emergency services immediately upon the appearance of any severe symptoms. Official management protocols state that no specific antidote is known for the combined formulation. Treatment is symptomatic and supportive, requiring continuous ECG monitoring and observation to manage the documented risks related to cardiac and neurological function.

Therapeutic Uses of Ascodex Plus

The utility of Ascodex Plus is generally applied across domains where additional symptomatic support is needed, primarily focusing on two symptom axes related to acute respiratory discomfort. It is relevant across acute therapeutic contexts.

Managing Symptoms of Congestion and Wet Cough

This medication is commonly used to help with managing symptom clusters that appear suddenly or intensify over time, such as a wet, productive cough and chest congestion. It is considered relevant in conditions characterized by periods of heightened symptoms, specifically acute bronchitis and the common cold. The combination of actions is consistent with general guidance for symptomatic relief across acute therapeutic contexts. Expectorant components are relevant for easing the symptoms of difficulty clearing thick phlegm. The medication is commonly used to help with easing the overall symptom load, supporting the process of relieving symptoms related to retained secretions, and contributing to improved day-to-day comfort during symptomatic periods.

Easing Symptoms Related to Persistent Cough Distress

This formulation is applied in clinical settings that involve acute or unstable symptom patterns, particularly where persistent coughing leads to symptoms that create noticeable physiological strain. It may assist with managing symptoms related to the intensity and frequency of the cough reflex, which often becomes more disruptive during flare-ups. This provides supportive relief when symptoms interfere with routine activities, offering symptomatic relief that helps patients cope more steadily with difficult episodes, particularly when the cough interrupts rest.

Quick Fact: Relief for Acute Respiratory Discomfort The medicine is commonly used for managing conditions that present with disruptive symptom manifestations, including persistent chest congestion, wet cough, and cough-related sleep interference, typically during seasonal respiratory illnesses.

Regulatory References

Health Canada guidance on cough preparations

Eligibility and Restrictions for Use

Regulatory Eligibility Profile

This medicine's official use is governed by a strict eligibility profile defined in authoritative regulatory documents, classifying populations based on contraindications and the need for medical consultation.

Absolute Prohibitions (Contraindications)

Population/Condition	Eligibility Status
Hypersensitivity	Contraindicated (Allergy to any component is an absolute exclusion).
Persistent Cough	Must Not Be Used (Exclusions include cough associated with smoking, asthma, emphysema, or cough accompanied by excessive secretions).

Restricted and Conditional Use

Official labeling requires caution or medical consultation for the following groups:

Pediatric Use: Generally not recommended for children younger than four years old. Regulatory advisories recommend cough and cold medications must not be prescribed to children under two years of age.
Pregnancy and Lactation: Use is not recommended or advised to be avoided in both pregnant and breastfeeding women due to limited human safety data and the risk of the drug being excreted in breast milk.
Comorbidities: Caution is required in patients with specific pre-existing conditions, including diabetes (requires blood sugar monitoring), hypertension, glaucoma, overactive thyroid, peptic ulcers, or a history of fits (epilepsy), as well as severe renal or hepatic impairment.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile for Ascodex Plus, a multi-component agent, is defined by regulatory constraints related to its active ingredients.

Contraindicated Combinations and Mandatory Restrictions

Co-administration with Monoamine Oxidase Inhibitors (MAOIs) is formally contraindicated, requiring a separation of at least 14 days following discontinuation of the MAOI. Use with the drug Eliglustat is also contraindicated due to documented metabolic inhibition by a component of Ascodex Plus, leading to increased systemic exposure of Eliglustat. Co-administration with calcium/magnesium/potassium/sodium oxybates is prohibited due to the risk of severe CNS depression.

Interactions Affecting Exposure and Function

The combination presents a pharmacodynamic risk of additive Central Nervous System (CNS) depression when taken with alcohol or other CNS Depressants, including opioids, benzodiazepines, and tranquilizers. Use with other Anticholinergic Medications may intensify anticholinergic effects. Bromhexine is documented to increase the concentration of certain antibiotics (such as amoxicillin, cefuroxime, erythromycin, and doxycycline) in the lung tissue.

Procedural and Population Considerations

The Guaifenesin component may interfere with specific clinical laboratory tests, including the determination of 5-hydroxyindoleacetic acid (5-HIAA) and vanillylmandelic acid (VMA), potentially yielding inaccurate results. Regulatory notes advise that the clearance of Bromhexine or its metabolites may be reduced in individuals with severe hepatic or renal impairment.

Mechanism of Action

The mechanism of Ascodex Plus is defined by the coordinated action of five components across two primary physiological domains: the rheology (flow properties) of respiratory secretions and the neurophysiological control of the cough reflex.

Modulating Mucus Viscosity and Fluid Volume

Bromhexine acts as a mucolytic by promoting the hydrolysis of acid mucopolysaccharide fibers via lysosomal activation, which reduces the stickiness of the mucus matrix. Simultaneously, Guaifenesin and Ammonium Chloride trigger reflex pathways from the gastric and bronchial mucosa to increase the secretion volume of low-viscosity fluid. This synergy modifies the physical state of the retained secretions, supporting mucociliary transport capacity.

Suppressing the Central and Reflexive Cough Drive

Diphenhydramine exerts its central antitussive effect by antagonizing the Histamine H1 receptors in the Medullary Cough Center of the CNS, elevating the threshold for cough initiation. Additionally, Menthol acts locally by activating the TRPM8 ion channel in upper airway sensory nerves, which generates a rapid, soothing, inhibitory reflex signal to the cough center. This dual control modulates the overall excitability of the cough reflex.

Anticholinergic Influence on Secretory Glands

A secondary effect arises from Diphenhydramine's antagonism of Muscarinic Acetylcholine Receptors (mAChR). This action on autonomic pathways reduces glandular activity and systemic secretions, which may limit the serous fluid volume required for the expectorant action, representing a key mechanistic constraint of the combined formulation.

Dosage and Administration Information

How Ascodex Plus is used

Ascodex Plus is formulated as an Oral Solution (Syrup), which defines the fundamental approach to its administration. Usage protocols for this multi-component preparation focus primarily on the route of administration and the necessity for precise measurement to ensure consistent delivery of the expectorant, mucolytic, and antihistamine components. The medicine's use is structured around a principle of short-term treatment for acute symptomatic periods.

Administration Scope

Instruction Entity	Status
Route of administration	Oral
Dosing schedule	Not explicitly documented.
Timing in relation to meals (if applicable)	Not explicitly documented.
Preparation requirements (if applicable)	Requires measuring using a calibrated device consistent with the liquid dosage form.
Age-group administration rules	Not explicitly documented.
Missed-dose rules	Not explicitly documented.
Special procedural conditions	Use is limited to short-term episodes of acute respiratory discomfort.

Instruction Classifications (High-Level)

Classification	Status
Administration method type	Oral
Frequency pattern	The pattern is based on scheduled, repeated intake during the acute episode, but the specific interval is not explicitly documented.
Basis of use	Derived from the standard application of its active components in a liquid oral format.
Use-context constraints	Limited to short-term use for acute symptom management.

Resulting Procedural Structure

General step sequence:

The medicine is administered orally as a solution.
The dose is measured using a calibrated device designed for the liquid form.
The usage follows a short-term duration principle.

Connection to the overall use protocol: The administration protocol for Ascodex Plus is defined by its oral route and solution form, which necessitates the use of a volumetric measuring device for consistent intake. This usage follows a short-term pattern, positioning the medicine as a temporary intervention for acute respiratory symptoms.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Ascodex Plus

The research base for Ascodex Plus, a combination medicine, includes studies that research examined its individual components (such as expectorants, mucolytics, and an H1-antagonist). Studies help show what has been observed so far regarding these components in managing symptoms associated with acute respiratory discomfort, but findings describe group patterns, not personal outcomes.

Research Evidence for Managing Wet Cough and Chest Congestion

Research was studied for the components used for wet, productive cough and chest congestion—namely, the expectorants and mucolytic. These studies were mostly short-term randomized controlled trials (RCTs) that research examined how symptoms change over time in adults experiencing conditions involving periods of heightened symptoms.

The trials monitored patient-reported outcomes describing perceived discomfort, including the intensity and frequency of cough, and patient-reported changes in the perceived ease of clearing thick mucus. Evidence contributes to understanding symptom patterns, but findings were mixed across various studies. The overall evidence certainty for this class of over-the-counter ingredients is limited.

What remains uncertain is the specific contribution of this full five-component fixed-dose combination versus the individual components. Data for certain groups remain insufficient regarding long-term effects, as the follow-up durations were limited—meaning long-term effects are not fully established.

Research Evidence for Addressing Cough-Related Irritation and Sleep Interference

Research was evaluated in trials focusing on the H1-antagonist component, a component where studies explored outcomes related to cough-related irritation and sleep. These short-term trials applied in studies examining patient-reported experiences in adults with cough that interfered with rest.

The studies monitored metrics, specifically focusing on patient-reported measures of sleep and cough frequency. Findings indicate that the observed patterns was associated with the sedating properties of the component. Research provides insight into short-term changes over the course of a few nights.

Key Limitations and Areas of Scientific Uncertainty

The research landscape for this type of medication includes several scientific challenges. Evidence quality varies across studies, and sample sizes were modest in some of the foundational trials. Findings were mixed when summarizing the outcomes of single components across systematic reviews. Furthermore, comparative evidence is lacking for the exact five-component FDC used in Ascodex Plus. Research is ongoing across the therapeutic class to better understand these outcomes.

Key Studies & References

Frequently Asked Questions (FAQ)

Common questions about Ascodex Plus (FAQ)

Q: What is the pregnancy safety category for Ascodex Plus?

A: Official labeling advises that use is generally not recommended during pregnancy or while breastfeeding due to limited human safety data on the combination. Official guidance indicates the risk/benefit profile is generally not established for these patient groups.

Q: Is a metallic taste or dry mouth listed as a possible side effect of Ascodex Plus?

A: Dry mouth is associated with the anticholinergic action of one of the active ingredients, Diphenhydramine, as described in official documents regarding the medicine's mechanism. A metallic taste is not generally highlighted in official documents as a common adverse reaction.

Q: Can Ascodex Plus cause feelings of nervousness or jitteriness?

A: Official information indicates that one of the active ingredients, Diphenhydramine, is sometimes associated with effects on the central nervous system. These documented effects may include feelings of nervousness, agitation, or restlessness, particularly in some individuals.

Q: Are there any known interactions between Ascodex Plus and medicines for blood pressure?

A: Official documents advise caution for individuals with pre-existing heart conditions, including hypertension (high blood pressure). One component of the medicine is documented to potentially cause an increase in heart rate (tachycardia) or palpitations, necessitating medical caution.

Q: Can Ascodex Plus be bought over the counter?

A: The classification of Ascodex Plus (as Prescription or Over-the-Counter) may differ depending on the national regulatory authority. The official status of this specific combination is determined by the regulatory rules of the country where it is marketed.

Q: Are the active ingredients in Ascodex Plus similar to other branded products?

A: The active ingredients, such as Guaifenesin and Diphenhydramine, are common components used in many other single-ingredient and combination cough and cold preparations. These components are listed in regulatory databases worldwide, indicating their use across various other products.

Q: How long does it usually take for Ascodex Plus to start working?

A: While regulatory labeling does not provide a specific time-to-effect for the combination, information regarding the components suggests the onset of effects may commence within 30 minutes to 2 hours following oral administration.

Q: How many hours does the effect of Ascodex Plus last?

A: The duration of action is related to the dosage frequency established in the official prescribing information for this medicine. The frequency typically guides repeated intake during the acute episode to maintain the desired therapeutic effect.

Q: Is it normal to feel a bit drowsy after taking Ascodex Plus?

A: Drowsiness and sleepiness are listed in official documents as commonly reported adverse reactions associated with this medicine. Individuals should observe the official caution to avoid driving or operating machinery if drowsiness is experienced.

Q: What should I know about food restrictions while using Ascodex Plus?

A: Official documents for the active ingredients indicate that administration can generally occur with or without food. The medicine is primarily defined by the oral route and the requirement for precise volumetric measurement, rather than meal timing.

Q: Can I use Ascodex Plus if I have an existing heart condition?

A: Official cautions advise individuals with pre-existing cardiac disorders, such as hypertension, require caution and medical consultation before use. This is due to the potential for certain components to affect heart rate and blood pressure.

Q: Is Ascodex Plus a prescription drug in all countries?

Q: Why is Ascodex Plus sometimes described as a combination medicine?

A: Ascodex Plus is classified in official documents as a fixed-dose combination (FDC) medicine. This is because it strategically integrates five distinct active ingredients from multiple pharmacological classes (such as expectorant, mucolytic, and antihistamine) within a single formulation.

Q: Does Ascodex Plus contain a stimulant ingredient?

A: Official documentation for the active ingredients lists a mucolytic, expectorants, an H1-antagonist, and a soothing agent. None of these primary components are classified as systemic stimulant medications.

Q: Is it necessary to drink extra water when taking Ascodex Plus?

A: While official administration instructions do not mandate drinking extra water, the expectorant components function by increasing the volume of fluid in the airways. Maintaining adequate overall fluid intake is a generally accepted practice that supports the body's natural processes related to mucus clearance.

Q: What are the official guidelines regarding the maximum duration of use for Ascodex Plus?

A: Official usage is formally constrained by a short-term duration principle for the management of acute symptoms. If a cough or associated symptoms persist beyond the short-term duration principle, official guidance advises consulting a healthcare professional.

Q: Is Ascodex Plus known to be habit-forming?

A: The active ingredients in Ascodex Plus are not classified as controlled substances and are not documented in official sources to be associated with habit-forming properties.

Q: Why do some people experience stomach upset with Ascodex Plus?

A: Adverse reactions like nausea, vomiting, diarrhea, and indigestion are documented as common gastrointestinal side effects. These effects can be caused by the expectorant components when administered orally.

Q: Is there a generic version of Ascodex Plus available?

A: A generic version would contain the identical five active ingredients and formulation as Ascodex Plus. Availability is governed by regional intellectual property laws and regulatory approval processes in each specific market.

Q: Can Ascodex Plus be crushed or chewed?

A: Ascodex Plus is an oral solution (syrup), not a tablet or capsule, and therefore must be precisely measured and swallowed as a liquid. Official administration instructions do not apply to crushing, chewing, or otherwise altering the liquid form.

Q: Are there different strengths or formulations of Ascodex Plus?

A: In various markets, regulatory authorities have approved different formulations (e.g., a 'Junior' variant) and strengths of Ascodex products. These are tailored for specific age groups or varying symptom profiles.

Q: Is it common for Ascodex Plus to be recommended for nighttime relief?

A: Because drowsiness and sleepiness are listed as common adverse reactions due to the Diphenhydramine component, the medicine is often associated with products intended for use when rest is desired.

Q: Does Ascodex Plus affect the results of any common medical tests?

A: Regulatory notes advise that the Guaifenesin component may interfere with specific clinical laboratory tests. This could potentially yield inaccurate results for the determination of 5-hydroxyindoleacetic acid (5-HIAA) and vanillylmandelic acid (VMA).

Q: Can seniors (over 65) use Ascodex Plus without special considerations?

A: Official advisories recommend caution when using this product in older adults. Caution is advised for those with pre-existing conditions like glaucoma, hypertension, or impaired kidney or liver function, as they may be more susceptible to certain adverse reactions.

Q: Can I use Ascodex Plus if I am taking an antibiotic?

A: Regulatory documents note that the Bromhexine component may increase the concentration of certain antibiotics, such as amoxicillin or erythromycin, in the lung tissue. This interaction is officially documented.

How should Ascodex Plus be stored and disposed of?

Storage and Disposal Requirements for Ascodex Plus

The storage and disposal of Ascodex Plus oral solution must adhere strictly to the conditions defined in the official regulatory documentation.

Official Storage Conditions

Requirement	Specific Instruction
Temperature	Store at room temperature, generally below 30 C; avoid excessive heat.
Protection	Protect from direct sunlight and keep the product in a cool, dry place.
Container Rule	Keep the medicine in its original container and ensure the cap is tightly closed after use.
Child Safety	Mandatory to keep out of the sight and reach of children and pets.

Disposal Instructions

Ascodex Plus must not be used after the expiry date printed on the packaging. Any unused or expired syrup must be discarded appropriately. Regulatory guidance prohibits disposing of the medicine via household trash or flushing it down a sink or toilet. Consultation with a pharmacist or local waste disposal service is required for proper disposal procedures.

Ascodex Plus